← Scroll for more →
Corvus Pharmaceuticals, Inc. (CRVS)
Pharmaceutical Preparations
Latest Price
$10.03
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.68
P/B Ratio
3.74
Institutional Ownership
85.1% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 7.17M | $107.0M | 8.52% | -- | 2026-06-30 |
| BlackRock, Inc. | 7.14M | $106.0M | 8.49% | +978.4K | 2026-06-30 |
| State Street Corp | 4.47M | $66.0M | 5.32% | +908.1K | 2026-06-30 |
| Price T Rowe Associates Inc | 3.79M | $56.0M | 4.50% | +871.8K | 2026-06-30 |
| Vanguard Capital Management LLC | 3.29M | $49.0M | 3.91% | +58.2K | 2026-06-30 |
| Adams Street Partners LLC | 3.28M | $48.0M | 3.89% | -- | 2026-06-30 |
| Vivo Capital, LLC | 2.81M | $41.0M | 3.34% | -- | 2026-06-30 |
| Wellington Management Group LLP | 2.73M | $40.0M | 3.25% | +413.1K | 2026-06-30 |
| Perceptive Advisors LLC | 2.67M | $39.0M | 3.17% | +375.0K | 2026-06-30 |
| Deep Track Capital, LP | 2.49M | $37.0M | 2.96% | +400 | 2026-06-30 |